Chronic lymphocytic leukemia patients with<scp><i>IGH</i></scp>translocations are characterized by a distinct genetic landscape with prognostic implications
Claudia Pérez‐Carretero, María Hernández‐Sánchez, Teresa González, Miguel Quijada‐Álamo, Marta Martín‐Izquierdo, Jesús‐María Hernández‐Sánchez, María‐Jesús Vidal, Alfonso García de Coca, Carlos Aguilar, Manuel Vargas‐Pabón, Sara Alonso, Magdalena Sierra, Araceli Rubio‐Martínez, Julio Dávila, José R. Díaz‐Valdés, J. A. Queizan, José‐Ángel Hernández‐Rivas, Rocío Benito, Ana E. Rodríguez‐Vicente, Jesús María Hernández‐Rivas
Abstract
Chromosome 14q32 rearrangements/translocations involving the immunoglobulin heavy chain (IGH) are rarely detected in chronic lymphocytic leukemia (CLL). The prognostic significance of the IGH translocation is controversial and its mutational profile remains unknown. Here, we present for the first time a comprehensive next-generation sequencing (NGS) analysis of 46 CLL patients with IGH rearrangement (IGHR-CLLs) and we demonstrate that IGHR-CLLs have a distinct mutational profile with recurrent mutations in NOTCH1, IGLL5, POT1, BCL2, FBXW7, ZMYM3, MGA, BRAF and HIST1H1E genes. Interestingly, BCL2 and FBXW7 mutations were significantly associated with this subgroup and almost half of BCL2, IGLL5 and HISTH1E mutations reported were previously identified in non-Hodgkin lymphomas. Notably, IGH/BCL2 rearrangements were associated with a lower mutation frequency and carried BCL2 and IGLL5 mutations, while the other IGHR-CLLs had mutations in genes related to poor prognosis (NOTCH1, SF3B1 and TP53) and shorter time to first treatment (TFT). Moreover, IGHR-CLLs patients showed a shorter TFT than CLL patients carrying 13q-, normal fluorescence in situ hybridization (FISH) and +12 CLL, being this prognosis particularly poor when NOTCH1, SF3B1, TP53, BIRC3 and BRAF were also mutated. The presence of these mutations not only was an independent risk factor within IGHR-CLLs, but also refined the prognosis of low-risk cytogenetic patients (13q-/normal FISH). Hence, our study demonstrates that IGHR-CLLs have a distinct mutational profile from the majority of CLLs and highlights the relevance of incorporating NGS and the status of IGH by FISH analysis to refine the risk-stratification CLL model.